Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Journal of Cardiovascular Electrophysiology
|
June 1, 1997
Radiofrequency ablation-induced asystole during transaortic approach for a left anterolateral accessory pathway: a Bezold-Jarisch-like phenomenon
C F Tsai, S A Chen, C E Chiang, et al.
Clinical Genetics
|
May 11, 2007
Current status of thalassemia in minority populations in Guangxi, China
H F Pan, G F Long, Q Li, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|
February 1, 1997
Radiofrequency catheter ablation of slow pathway in 760 patients with atrioventricular nodal reentrant tachycardia--long-term results
W C Yu, S A Chen, C T Tai, et al.
Journal of the American College of Cardiology
|
April 1, 1997
Effect of high intensity drive train stimulation on dispersion of atrial refractoriness: role of autonomic nervous system
W C Yu, S A Chen, C E Chiang, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|
February 1, 1997
Long-term results of radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome
Y J Chen, S A Chen, C T Tai, et al.
Journal of Cardiovascular Electrophysiology
|
March 25, 1998
Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias
C T Tai, S A Chen, C E Chiang, et al.
Circulation
|
November 14, 1997
Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter
C T Tai, S A Chen, C E Chiang, et al.
Mucosal Immunology
|
March 5, 2015
Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis
C Ning, Y-Y Li, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2014
Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial
Q Zhou, Y Cheng, J-J Yang, et al.
ESMO Open
|
July 26, 2024
Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials
F-R Liu, X-L Wei, W-N Feng, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Journal of Cardiovascular Electrophysiology
|
June 1, 1997
Radiofrequency ablation-induced asystole during transaortic approach for a left anterolateral accessory pathway: a Bezold-Jarisch-like phenomenon
C F Tsai, S A Chen, C E Chiang, et al.
Clinical Genetics
|
May 11, 2007
Current status of thalassemia in minority populations in Guangxi, China
H F Pan, G F Long, Q Li, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|
February 1, 1997
Radiofrequency catheter ablation of slow pathway in 760 patients with atrioventricular nodal reentrant tachycardia--long-term results
W C Yu, S A Chen, C T Tai, et al.
Journal of the American College of Cardiology
|
April 1, 1997
Effect of high intensity drive train stimulation on dispersion of atrial refractoriness: role of autonomic nervous system
W C Yu, S A Chen, C E Chiang, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|
February 1, 1997
Long-term results of radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome
Y J Chen, S A Chen, C T Tai, et al.
Journal of Cardiovascular Electrophysiology
|
March 25, 1998
Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias
C T Tai, S A Chen, C E Chiang, et al.
Circulation
|
November 14, 1997
Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter
C T Tai, S A Chen, C E Chiang, et al.
Mucosal Immunology
|
March 5, 2015
Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis
C Ning, Y-Y Li, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2014
Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial
Q Zhou, Y Cheng, J-J Yang, et al.
ESMO Open
|
July 26, 2024
Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials
F-R Liu, X-L Wei, W-N Feng, et al.
Page
of 16